Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 9/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.59 |
| ▸ | TTR | P02766 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.49 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.49 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.45 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.45 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15877543 | 0.83 | GRM5 (0.56) | GRM5KCNH2TTR | |
| SCHEMBL5778843 | 0.83 | GRM5 (0.62) | GRM5KCNH2TTRCYP2D6CYP1A2 | |
| SCHEMBL12884286 | 0.81 | GRM5 (0.65) | GRM5KCNH2TTRCYP2D6CYP1A2 | |
| SCHEMBL15877300 | 0.78 | GRM5 (0.67) | GRM5KCNH2CYP2D6CYP1A2PIK3CA | |
| SCHEMBL15877460 | 0.78 | GRM5 (0.67) | GRM5KCNH2TTRCYP2D6CYP1A2 | |
| SCHEMBL15877099 | 0.78 | GRM5 (0.67) | GRM5KCNH2CYP2D6CYP1A2PIK3CA | |
| SCHEMBL3796332 | 0.76 | CYP2A6 (0.67) | GRM5CYP2D6CYP1A2CHRNB2CHRNA4 | |
| SCHEMBL12884290 | 0.76 | TTR (0.62) | GRM5KCNH2TTRCYP1A2 | |
| SCHEMBL15877643 | 0.75 | GRM5 (1.00) | GRM5KCNH2CYP2D6CYP1A2PIK3CA | |
| SCHEMBL401836 | 0.74 | GRM5 (0.64) | GRM5CYP2D6CYP1A2PIK3CAPDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8946431-B2 | 2-(substituted ethynyl)quinoline derivatives as mGLUr5 antagonists | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2015-02-03 | — | — | US | claimed |
| US-20140206876-A1 | 2-(Substituted ethynyl)quinoline Derivatives as mGLUr5 Antagonists | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2014-07-24 | — | — | US | claimed |
| US-8946431-B2 | 2-(substituted ethynyl)quinoline derivatives as mGLUr5 antagonists | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2015-02-03 | — | — | US | disclosed |
| US-20140206876-A1 | 2-(Substituted ethynyl)quinoline Derivatives as mGLUr5 Antagonists | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2014-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140206876-A1 | 2-(Substituted ethynyl)quinoline Derivatives as mGLUr5 Antagonists | GRM5, GRIK5, GRIA4 | GRM5 1/4885KCNH2 1318/4885TTR 3319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.